Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons

被引:7
|
作者
Monamele, Chavely Gwladys [1 ,2 ]
Njifon, Hermann Landry Munshili [3 ,4 ]
Vernet, Marie-Astrid [1 ]
Njankouo, Mohamadou Ripa [1 ]
Kenmoe, Sebastien [1 ]
Yahaya, Ali Ahmed [5 ]
Deweerdt, Louis [3 ]
Nono, Raphael [3 ]
Mbacham, Wilfred [4 ]
Anong, Damian Nota [2 ]
Akoachere, Jane Francis [2 ]
Njouom, Richard [1 ]
机构
[1] Ctr Pasteur Cameroon, Natl Influenza Ctr, Yaounde, Cameroon
[2] Univ Buea, Buea, Cameroon
[3] Ctr Pasteur Cameroon, Annex Of Garoua, Garoua, Cameroon
[4] Univ Yaounde I, Yaounde, Cameroon
[5] WHO, Reg Off Africa, Brazzaville, Rep Congo
来源
PLOS ONE | 2019年 / 14卷 / 01期
关键词
GENETIC-CHARACTERIZATION; VIRUSES; HEMAGGLUTININ; EPIDEMIOLOGY; A(H3N2); H1N1;
D O I
10.1371/journal.pone.0210119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In 2009, Influenza A(H1N1)pdm09 caused the first influenza pandemic of the 21st century with high mortality rates of about 284 500 deaths. This virus, however, continues to circulate as a seasonal influenza virus and to cause illness and deaths worldwide. In this study, we describe the genetic diversity of A(H1N1)pdm09 viruses collected between 2014 and 2016 in Cameroon. Three gene segments (HA, NA and M) of Cameroon strains were studied. The phylogenetic tree of the coding nucleotide sequences was generated by MEGA version 6.0 using a Maximum Likelihood method. The NA and M protein coding sequences were analyzed for the reported genetic markers of resistance against neuraminidase inhibitors and adamantanes, while predicted vaccine efficacy was estimated using the P-epitope method. Overall 39 strains were obtained. Phylogenetic analysis of the HA gene of influenza A(H1N1)pdm09 showed that Cameroon strains belonged to two major clades. The 2014 Cameroon sequences belonged to clade 6C while all sequences collected between 2015 and 2016 belonged to clade 6B. Majority of the samples had some mutations in the NA gene notably: I117M, N248D, and N369K while the amantadine-resistant M mutant, S31N, was found to be absent only in the two sequences collected in 2014. Overall, A/California/07/2009 vaccine strain showed a predicted vaccine efficacy of 24.55% to 35.77% against Cameroon A(H1N1)pdm09 strains circulating between 2014 and 2016. Our findings confirms the fast evolution of A(H1N1)pdm09 since its first introduction and highlights on the importance of influenza vaccine in reducing the burden caused by influenza in the community.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Molecular features of influenza A (H1N1) pdm09 prevalent in Mexico during winter seasons 2012-2014
    Arellano-Llamas, Rocio
    Alfaro-Ruiz, Luis
    Arriaga Canon, Cristian
    Imaz Rosshandler, Ivan
    Cruz-Lagunas, Alfredo
    Zuniga, Joaquin
    Rebollar Vega, Rosa
    Wong, Christopher W.
    Maurer-Stroh, Sebastian
    Romero Cordoba, Sandra
    Liu, Edison T.
    Hidalgo-Miranda, Alfredo
    Vazquez-Perez, Joel A.
    PLOS ONE, 2017, 12 (07):
  • [2] Influenza A(H1N1)pdm09 and Postpandemic Influenza in Lithuania
    Ambrozaitis, Arvydas
    Radzisauskiene, Daiva
    Zagminas, Kestutis
    Kupreviciene, Nerija
    Gravenstein, Stefan
    Jancoriene, Ligita
    OPEN MEDICINE, 2016, 11 (01): : 341 - 353
  • [3] Estimating the burden of A( H1N1)pdm09 influenza in Finland during two seasons
    Shubin, M.
    Virtanen, M.
    Toikkanen, S.
    Lyytikainen, O.
    Auranen, K.
    EPIDEMIOLOGY AND INFECTION, 2014, 142 (05): : 964 - 974
  • [4] Influenza A(H1N1)pdm09 during air travel
    Neatherlin, John
    Cramer, Elaine H.
    Dubray, Christine
    Marienau, Karen J.
    Russell, Michelle
    Sun, Hong
    Whaley, Melissa
    Hancock, Kathy
    Duong, Krista K.
    Kirking, Hannah L.
    Schembri, Christopher
    Katz, Jacqueline M.
    Cohen, Nicole J.
    Fishbein, Daniel B.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2013, 11 (02) : 110 - 118
  • [5] Influenza A(H1N1)pdm09 virus and asthma
    Obuchi, Masatsugu
    Adachi, Yuichi
    Takizawa, Takenori
    Sata, Tetsutaro
    FRONTIERS IN MICROBIOLOGY, 2013, 4
  • [6] Influenza A(H1N1)pdm09 virus: therapeutics and challenges
    Saxena, Shailendra K.
    Kotikalapudi, Rosaiah
    Tiwari, Sneham
    Muvva, Charuvaka
    FUTURE VIROLOGY, 2012, 7 (10) : 947 - 950
  • [7] Neurological events related to influenza A (H1N1) pdm09
    Cardenas, Graciela
    Luis Soto-Hernandez, Jose
    Diaz-Alba, Alexandra
    Ugalde, Yair
    Merida-Puga, Jorge
    Rosetti, Marcos
    Sciutto, Edda
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2014, 8 (03) : 339 - 346
  • [8] The 2015 influenza A (H1N1) pdm09 outbreak in India
    Murhekar, Manoj
    Mehendale, Sanjay
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 821 - 823
  • [9] A(H1N1) pdm09 influenza infection: vaccine inefficiency
    Friedman, Nehemya
    Drori, Yaron
    Pando, Rakefet
    Glatman-Freedman, Aharona
    Sefty, Hanna
    Bassal, Ravit
    Stein, Yaniv
    Shohat, Tamy
    Mendelson, Ella
    Hindiyeh, Musa
    Mandelboim, Michal
    ONCOTARGET, 2017, 8 (20) : 32856 - 32863
  • [10] Evolution of the Hemagglutinin Gene of the Influenza A(H1N1)pdm09 Virus in Morocco During Two Influenza Seasons 2009–2011
    Hicham El Rhaffouli
    El Mostafa El Fahime
    Abdellilah Laraqui
    Tahar Bajjou
    Marouane Melloul
    Susan Obeid
    Lahoussine Fathallah
    Idriss Lahlou-Amine
    Current Microbiology, 2014, 68 : 372 - 380